PMGC Capital LLC
Search documents
PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.
Globenewswire· 2026-01-06 12:30
Industry Overview - The U.S. small and micro modular reactor (SMR/MMR) market is experiencing rapid growth due to energy security needs, data center demand, and federal support for advanced nuclear technologies [1][2] - The global SMR market, including MMRs, is projected to grow from approximately $7.5 billion in 2025 to over $16 billion by 2034, representing a compound annual growth rate (CAGR) of about 9% [3] Company Investment - PMGC Holdings Inc. has announced that its investment arm, PMGC Capital LLC, has acquired non-controlling shares in Nuclea Energy Inc., which focuses on the development of Micro Modular Reactor (MMR) and advanced nuclear energy solutions [1] - This investment aligns with PMGC Capital's strategic focus on supporting companies within long-term growth trends, including next-generation energy infrastructure and decarbonization [2] Nuclea Energy Inc. Profile - Nuclea Energy aims to provide clean, reliable, and economically competitive nuclear energy by replacing high-cost fossil fuels with micro nuclear technology [4] - The company is developing its Morpheus micro reactor for commercial readiness, targeting off-grid applications such as remote communities and military infrastructure [4] PMGC Capital LLC Profile - PMGC Capital is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies across diverse markets [5] - The firm's mission is to identify high-potential opportunities to deliver sustainable growth and maximize returns on capital [5] PMGC Holdings Inc. Profile - PMGC Holdings Inc. is a diversified holding company that manages its portfolio through strategic acquisitions and investments across various industries [6] - The company is committed to exploring opportunities in multiple sectors to maximize growth and value [6]
Elevai Labs(ELAB) - Prospectus(update)
2025-11-26 01:15
As filed with the U.S. Securities and Exchange Commission on November 25, 2025. Registration No. 333-290902 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) Nevada 5912 33-2382547 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R. ...
Elevai Labs(ELAB) - Prospectus(update)
2025-11-26 01:10
As filed with the U.S. Securities and Exchange Commission on November 25, 2025. Registration No. 333-290428 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) Nevada 5912 33-2382547 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R. ...
Elevai Labs(ELAB) - Prospectus
2025-10-15 23:28
As filed with the U.S. Securities and Exchange Commission on October 15, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 5912 33-2382547 (I.R.S. Employer Identification ...
Elevai Labs(ELAB) - Prospectus(update)
2025-10-15 20:47
As filed with the U.S. Securities and Exchange Commission on October 15, 2025. Registration No. 333-290428 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Nevada 5912 33-2382547 (Primary Standard Industrial (I.R.S. Employer Classification Co ...
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
Globenewswire· 2025-06-18 13:52
Core Viewpoint - PMGC Capital LLC urges Alaunos Therapeutics, Inc. to accept a financing term sheet that could provide substantial capital and create significant shareholder value [1][4]. Group 1: PMGC Capital's Position - PMGC Capital holds a significant ownership position in Alaunos and is acting in the best interest of all shareholders [2]. - The proposed financing, introduced by PMGC Capital and led by a leading Wall Street bank, is described as a compelling opportunity for Alaunos [3]. - PMGC Capital emphasizes the importance of engaging with the bank to maximize long-term value for shareholders [4]. Group 2: Financing Details - The financing offer is characterized as non-toxic and well-structured, providing substantial capital to Alaunos [4]. - PMGC Capital commends Alaunos for maintaining a clean capital structure and prudent financial management during challenging market conditions [5]. Group 3: Company Background - PMGC Capital is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies across diverse markets [6]. - PMGC Holdings Inc. manages a diversified portfolio through strategic acquisitions and investments across various industries [7].
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
Globenewswire· 2025-05-14 20:30
Company Overview - PMGC Holdings Inc. has filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2025, with the SEC [1] - The company is well-capitalized with a strong balance sheet and a defined business focus [2] Operating Subsidiaries - NorthStrive Biosciences Inc. focuses on developing aesthetic medicines, with its lead asset EL-22 aimed at preserving muscle during weight loss treatments [2] - PMGC Research Inc. utilizes Canadian research grants and collaborates with universities to accelerate scientific discovery [3] - PMGC Capital LLC is a multi-strategy investment firm that seeks undervalued companies and assets to maximize returns [4] Strategic Growth Initiatives - The company is actively pursuing acquisitions of B2B businesses and assets to drive revenue growth and enhance shareholder value [2] - On April 16, 2025, PMGC announced a non-binding Letter of Intent to acquire a cash-flow-positive IT custom packaging company [5] Company Commitment - PMGC is committed to exploring opportunities across various sectors to maximize growth and value [6]